BRPI0908309A2 - "método in vitro ou in vivo de seleção de compostos e uso dos genes ou proteínas carboxilesterase 1 e/ou carboxilesterase 3" - Google Patents
"método in vitro ou in vivo de seleção de compostos e uso dos genes ou proteínas carboxilesterase 1 e/ou carboxilesterase 3"Info
- Publication number
- BRPI0908309A2 BRPI0908309A2 BRPI0908309-0A BRPI0908309A BRPI0908309A2 BR PI0908309 A2 BRPI0908309 A2 BR PI0908309A2 BR PI0908309 A BRPI0908309 A BR PI0908309A BR PI0908309 A2 BRPI0908309 A2 BR PI0908309A2
- Authority
- BR
- Brazil
- Prior art keywords
- carboxylesterase
- genes
- vitro
- proteins
- vivo method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7159308P | 2008-05-07 | 2008-05-07 | |
FR0857715A FR2938342A1 (fr) | 2008-11-13 | 2008-11-13 | Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee |
PCT/EP2009/055561 WO2009135916A1 (en) | 2008-05-07 | 2009-05-07 | Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0908309A2 true BRPI0908309A2 (pt) | 2015-08-18 |
Family
ID=40790878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0908309-0A BRPI0908309A2 (pt) | 2008-05-07 | 2009-05-07 | "método in vitro ou in vivo de seleção de compostos e uso dos genes ou proteínas carboxilesterase 1 e/ou carboxilesterase 3" |
Country Status (9)
Country | Link |
---|---|
US (1) | US20110150774A1 (pt) |
EP (1) | EP2283158A1 (pt) |
JP (1) | JP2011519572A (pt) |
BR (1) | BRPI0908309A2 (pt) |
CA (1) | CA2723838A1 (pt) |
FR (1) | FR2938342A1 (pt) |
MX (1) | MX2010011729A (pt) |
RU (1) | RU2010150112A (pt) |
WO (1) | WO2009135916A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111406113B (zh) * | 2017-11-30 | 2024-04-16 | 花王株式会社 | 评价或选择感觉刺激降低剂的方法 |
JP6621796B2 (ja) * | 2017-11-30 | 2019-12-18 | 花王株式会社 | 感覚刺激低減剤の評価又は選択方法 |
WO2021092440A1 (en) * | 2019-11-07 | 2021-05-14 | Icahn School Of Medicine At Mount Sinai | Synthetic modified rna and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4233297A (en) * | 1996-08-23 | 1998-03-06 | Arch Development Corporation | Identification of activators and inhibitors of sebum formation |
YU57502A (sh) * | 2000-02-02 | 2006-01-16 | Warner-Lambert Company | Dvojni inhibitori sinteze estara holesterola i estara voska kod poremećaja lojne žlezde |
JP2007508291A (ja) * | 2003-10-09 | 2007-04-05 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 皮脂産生を減少させるためのマロンアミド誘導体を含んでなる医薬組成物 |
FR2903999B1 (fr) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee |
FR2904004B1 (fr) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | Modulateurs de scarb-1 dans le traitement de l'acne ou de l'hyperseborrhee |
-
2008
- 2008-11-13 FR FR0857715A patent/FR2938342A1/fr not_active Withdrawn
-
2009
- 2009-05-07 EP EP09742134A patent/EP2283158A1/en not_active Ceased
- 2009-05-07 BR BRPI0908309-0A patent/BRPI0908309A2/pt not_active IP Right Cessation
- 2009-05-07 WO PCT/EP2009/055561 patent/WO2009135916A1/en active Application Filing
- 2009-05-07 MX MX2010011729A patent/MX2010011729A/es unknown
- 2009-05-07 CA CA2723838A patent/CA2723838A1/en not_active Abandoned
- 2009-05-07 US US12/991,310 patent/US20110150774A1/en not_active Abandoned
- 2009-05-07 JP JP2011507931A patent/JP2011519572A/ja active Pending
- 2009-05-07 RU RU2010150112/10A patent/RU2010150112A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2283158A1 (en) | 2011-02-16 |
US20110150774A1 (en) | 2011-06-23 |
JP2011519572A (ja) | 2011-07-14 |
WO2009135916A1 (en) | 2009-11-12 |
RU2010150112A (ru) | 2012-06-20 |
CA2723838A1 (en) | 2009-11-12 |
MX2010011729A (es) | 2011-04-05 |
FR2938342A1 (fr) | 2010-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0909954A2 (pt) | "diazacarbazóis e métodos de uso" | |
SMT201400181B (it) | Composizioni per vasocostrizione e metodi d'uso | |
SMT201600278B (it) | Inibitori della benzossazolo chinasi e metodi d'uso | |
BRPI1012000A2 (pt) | "sistema combustores e métodos de uso dos mesmos" | |
BRPI0910852A2 (pt) | composições contendo lipídios e métodos de uso das mesmas | |
HRP20160859T1 (hr) | Modificirani proteini rsv f i postupci njihove upotrebe | |
BRPI0922708A2 (pt) | peptídeos mini-hepcidina e métodos de uso do mesmo | |
BRPI0808444A2 (pt) | análogos de ciclopamina lactam e métodos de uso dos mesmos | |
BRPI0909077A2 (pt) | Artigos multicamadas e métodos de preparo e uso dos mesmos | |
BRPI0821499A2 (pt) | Artigos de filtração de fluído e métodos de preparo e uso dos mesmos | |
PT2129296E (pt) | Dispositivo para medir as propriedades viscoelásticas de tecidos biológicos e procedimento utilizando este dispositivo | |
BR112012003661A2 (pt) | "compostos de biarila e métodos de uso dos mesmos." | |
EP2054063A4 (en) | 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE | |
BRPI0715402A2 (pt) | Marcadores de doença hepática gordurosa não alcoólica (nafld) e esteatohepatite não alcoólica (nash) e métodos de uso dos mesmos | |
BRPI1011876A2 (pt) | "composição farmacêutica estável e métodos de uso da mesma" | |
BRPI0913726A2 (pt) | rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos | |
EP2079363A4 (en) | SYSTEM AND METHOD FOR IN VIVO MEASUREMENT OF BIOLOGICAL PARAMETERS | |
BRPI0915959A2 (pt) | silanos de éter fluorados e métodos de uso dos mesmos | |
BRPI0916769A2 (pt) | derivados de benzilbenzeno deuterados e métodos de uso | |
BR112012002855A2 (pt) | "uso de um anticorpo anti-cd20 afucosilado e composição" | |
FR2937322B1 (fr) | Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues | |
BRPI1014544A8 (pt) | anticorpos anti-il-17f e metodos de uso dos mesmos | |
BRPI0914488A2 (pt) | "composições de limpeza incluindo siloxanos de sorbitano modificados e uso das mesmas" | |
EP2291654A4 (en) | PREPARATION AND COMPOSITION OF INTER ALPHA INHIBITOR PROTEINS FROM BLOOD | |
BRPI0907236A2 (pt) | inibidores de proteína quinase e uso dos mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2330 DE 01-09-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |